| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.45% | +1.76% | +54.96% | +118.11% | 1,135B | |
| +0.94% | +4.20% | +39.86% | +75.69% | 635B | |
| +0.39% | +0.46% | +25.77% | +97.40% | 505B | |
| +1.43% | +4.56% | +46.20% | +66.91% | 378B | |
| -3.21% | -3.66% | +60.72% | +35.68% | 358B | |
| -0.41% | +2.23% | +22.48% | +48.54% | 295B | |
| +0.23% | +3.28% | +2.57% | +21.89% | 266B | |
| +1.22% | +2.81% | +52.40% | +63.37% | 237B | |
| +1.70% | +1.60% | +31.21% | +102.44% | 193B | |
| Average | +0.24% | +1.60% | +37.35% | +70.00% | 444.85B | |
| Weighted average by Cap. | +0.31% | +1.63% | +41.40% | +81.03% |
Employees
4
Sector
Pharmaceuticals
